Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Makers Nutrition Holds Thanksgiving Food Drive for Island Harvest


Helping Neighbors in Need: Makers Nutrition Holds Thanksgiving Food Drive for Island Harvest

We are so pleased to give to those in need, especially when those in need are our neighbors.

Makers Nutrition has donated over 800 pounds worth of non-perishable food and household items to Island Harvest Food Bank.

For many, Thanksgiving is a time to cherish those surrounding the dinner table. As many fill their plates, others are without food and necessities that are often taken for granted. Each year, the Makers Nutrition team comes together to donate as much as possible to a Long Island-based charity organization. Considering all that Island Harvest Food Bank does to help people in need and seeing how much more they are doing in response to the COVID-19 crisis, Makers Nutrition knew this organization would be receiving a special donation.

Island Harvest Food Bank has gone above and beyond, running a COVID-19 response program across Suffolk and Nassau counties specifically to veterans, seniors, and children, and homebound individuals who are struggling with food insecurity.

“We are so pleased to give to those in need, especially when those in need are our neighbors,” said Vice President of Sales Patrick Gillespie. “As an Inc. 5000 company and Grand International Business Award winner, our employees understand the value of effort and teamwork. It’s just a great feeling when that effort and teamwork go toward a good cause.”

This is Makers Nutrition’s third time donating to Island Harvest Food Bank, and the team encourages all able to donate what they can. Any amount matters and can make a difference.

About Island Harvest Food Bank

Island Harvest Food Bank is a leading hunger-relief organization that provides food and other resources to people in need. Always treating those it helps with dignity and respect, its mission is to end hunger and reduce food waste on Long Island through efficient food collection and distribution; enhanced hunger-awareness and nutrition-education programs; job training; and direct services targeted at children, senior citizens, veterans, and others at risk of food insecurity. As a result of Island Harvest Food Bank’s dynamic business model, more than 94 percent of expended resources go directly to programs and services that support more than 300,000 Long Islanders facing hunger. Island Harvest Food Bank is a lead agency in the region’s emergency response preparedness for food and product distribution. It is a member of Feeding America®, the nation’s leading domestic hunger-relief organization. For five consecutive years, Island Harvest Food Bank has earned a four-star rating from Charity Navigator, a leading independent charity watchdog organization. Island Harvest Food Bank is among just 9% of the organizations rated by Charity Navigator to merit the four-star designation. More information about Island Harvest Food Bank is at http://www.islandharvest.org.

About Makers Nutrition

Makers Nutrition, an Inc. Fastest-Growing Business in America, is a groundbreaking provider for dietary supplement companies worldwide. Specializing in capsules, tablets, powders, softgels, and gummies, Makers Nutrition provides a full-service option for all contract manufacturing, graphic design, packaging, and fulfillment service needs.

Share article on social media or email:

Helixmith Announces First Patient Enrolled in Phase 3 Study of Engensis (VM202) for Diabetic Peripheral Neuropathy


“Patients with DPN experience high levels of pain and discomfort, with no medicine available that treats the underlying disease,” says Miguel Trevino, MD, Medical Director, Innovative Research of West Florida. “REGAiN-1A will inform the ongoing clinical efforts to develop a new potentially regenerative medicine therapy.”

DPN is one of the most common complications of diabetes. Of approximately 30 million US adults with diabetes, up to 50% may develop DPN, and disabling neuropathic pain (painful DPN or PDPN) may affect approximately 25% of patients with diabetes (Shillo et al., 2019) . Painful DPN typically manifests as burning or stabbing pain in the lower extremities. Currently approved medications for PDPN are palliative, limited to managing existing pain, and have the potential for serious side effects.

The primary efficacy endpoint for the REGAiN-1A trial compares the change in average daily pain scores from the 7 days prior to the first injection on Day 0 to the 7 days prior to the six-month visit in participants treated with Engensis versus placebo. Secondary endpoints include the statistical significance of (1) reduction in worst pain at the end of a six-month period versus placebo, (2) the ratio of patients with an average pain reduction of 50% or more at the end of the six-month period versus placebo, and (3) safety of Engensis versus placebo.

“Engensis represents a truly novel approach to treating neuromuscular diseases, including DPN,” notes Dr. Sunyoung Kim, CEO and Head of Global Clinical Development at Helixmith. “This latest clinical study will add to the considerable body of knowledge and evidence we’ve gathered to support the optimal use of Engensis in patients needing treatment options. “

Patients and clinical investigators seeking more information about the REGAiN-1A Phase 3 Clinical Trial can visit

https://www.clinicaltrials.gov/ct2/show/NCT04469270?term=NCT04469270&draw=2&rank=1

About Engensis

Helixmith’s Engensis (VM202) is a gene therapy based on plasmid DNA. To date, more than 500 patients have been treated with Engensis across ten clinical trials in six different diseases and conditions. Data from previous clinical studies suggest that Engensis is well tolerated and has the potential to provide durable analgesic and/or symptomatic relief in a variety of disease settings. Beyond potentially alleviating pain, Engensis is designed to target the underlying causes of neuropathy through its predicted angiogenic and neuroregenerative properties. The US FDA recognized the potential for Engensis to meet the unmet need for this condition in 2018 by designating it as a Regenerative Medicine Advanced Therapy (RMAT), making it the first RMAT-designated gene therapy for a prevalent disease with over one million patients. This designation grants all the benefits afforded by the fast track and breakthrough designations, including priority review, to Engensis.

About Helixmith

Helixmith is a gene therapy company headquartered in Seoul, Korea, developing new and innovative biopharmaceuticals to tackle previously untreated diseases, and is listed on KOSDAQ. The company has an extensive gene therapy pipeline, including a CAR-T program targeting several different types of solid tumors and an AAV vector program targeting neuromuscular diseases. Engensis (VM202), the most advanced pipeline candidate, is a plasmid DNA therapy being studied for DPN, diabetic foot ulcers, claudication, amyotrophic lateral sclerosis (Phase 2 beginning in late 2020), coronary artery disease and Charcot-Marie-Tooth disease.

Helixmith clinical development and manufacturing activities are based in San Diego, California, where the company co-owns a cGMP-ready DNA production facility, Genopis, Inc., an affiliated CDMO also in San Diego. Genopis serves both Helixmith and external customers in need of plasmid DNA for medical purposes.

Share article on social media or email:

Madonna University Keeps Campus Community Safe and Healthy During Pandemic Using ReturnSafe’s Biosecurity Platform


News Image

“Unfortunately, contact tracing or a vaccine alone are not the answer to keeping our communities healthy and safe,” said Tarun Nimmagadda, Chief Executive Officer of ReturnSafe.

Part of Madonna University’s plans to reopen its Livonia, Michigan campus this fall involved working with ReturnSafe. To students, staff and faculty safe and healthy during the Coronavirus pandemic, Madonna utilized ReturnSafe’s BioSecurity Platform.

“Over the summer we saw the devastating impact of COVID-19 and recognized that we would need to find a solution that our students, staff and faculty could use on a daily basis in order to bring everyone back safely,” said John Montgomery, Chief Information Technology Officer at Madonna University. “ReturnSafe is a simple health-screening and contact-tracing solution that gives us the reassurance needed in order to keep our doors open and our community safe. With ReturnSafe, we’re able to quickly identify those who have been potentially exposed to the virus and, in turn, those with whom they have been in contact. We have a university community of 2,400 students, faculty and staff who come to campus regularly, so it’s critical to be able to identify potential risk areas and respond rapidly to minimize the risk of an outbreak.”

Students and faculty register their health status using the ReturnSafe app by answering COVID-specific screening questions. Once cleared to come to campus, students, faculty, staff, and visitors receive a daily electronic “badge” that can be shown to faculty and staff as they attend classes or other events on campus. Those not cleared are requested to stay away from campus, and are provided with directions on necessary COVID-19 testing, isolation and quarantine procedures. In addition to identifying potentially-exposed or infected people, the ReturnSafe BioSecurity Platform helps Madonna University’s Chief Health Officer rapidly notify those who were potentially exposed.

“As a mission-driven company, we want to help educational institutions with a solution that allows them to confidently reopen their schools. Unfortunately, contact tracing or a vaccine alone are not the answer to keeping our communities healthy and safe,” said Tarun Nimmagadda, Chief Executive Officer of ReturnSafe. “Historically, we have seen other contagious diseases similar to the Coronavirus continue to spread in communities even with a vaccine so additional safety systems have to be in place. ReturnSafe features daily screening, test data management for those that may be positive and have been tested, and contact-tracing alerts that help slow the spread of the virus.”

The ReturnSafe BioSecurity Platform offers organizations an end-to-end solution that slows the spread of infectious diseases by implementing critical daily screening with a symptoms diary and recommendations governed by HR policies; testing data management for quick notification of a positive test; and Bluetooth contact-tracing via smartphone and hardware wearables at the workplace including a built-in social distancing alarm. To learn more, click to read the Madonna University case study.

About ReturnSafe

ReturnSafe is a mission-driven BioSecurity company focused on workplace health safety enabling businesses, healthcare organizations, educational institutions and others to prevent and rapidly respond to biological threats, keeping their communities safe and their doors open. ReturnSafe’s BioSecurity Platform is a human-centric solution that focuses on slowing the spread of infectious diseases by implementing critical daily screening, exposure notification and contact tracing case management. For more information, visit http://www.returnsafe.com.

About Madonna

Liberal arts education, career preparation, and service-learning have been the hallmarks of a Madonna University education for more than 80 years. In addition to the beautiful main campus, conveniently located at I-96 and Levan Road in Livonia, Mich., Madonna offers academic programs in Gaylord, Macomb, and online in China, Haiti, and the United Arab Emirates. Michigan’s most affordable, independent, Catholic, liberal arts university, Madonna offers more than 100 undergraduate and 35 graduate programs in the colleges of arts and sciences, education and human development, and nursing and health, as well as the School of Business.

Share article on social media or email:

Galen Data Publishes Comprehensive Whitepaper on Medical Device Cloud Connectivity


The Definitive Guide to Cloud Connectivity

The Definitive Guide to Medical Device Connectivity

Cloud-enabled healthcare innovation is poised to help millions across a range of conditions. Understanding the realistic costs and risks associated with medical device cloud connectivity is critical.

Galen Data Inc., announces the release of a 28-page whitepaper entitled “The Definitive Guide to Medical Device Connectivity,” which offers in-depth guidance on device-to-cloud connectivity for medical device companies. The guide is co-authored by a team of leading experts in medical device design and development, who have a combined 50+ years of experience in healthcare technology, medical devices, and regulatory compliance.

Cloud computing technologies have transformed countless industries. Over the last six years, there has been an ever-growing number of companies developing medical devices with a cloud dependence. Safely connecting devices to the cloud can be an incredibly time-consuming process and poses critical regulatory and financial risks. Knowing these risks and mitigation strategies early in the development process is critical to commercial success.

This comprehensive whitepaper provides guidance across a range of connectivity considerations, and answers the following questions:

  • Why should I connect a medical device to the cloud?
  • How is cloud computing and IoT (the Internet of Things) technology set to disrupt healthcare?
  • What are the steps needed to prepare for medical device connectivity?
  • What are the regulatory, cybersecurity, and privacy implications for a medical device?
  • What can I expect when building cloud connectivity in-house as compared to leveraging a third-party platform?

“This whitepaper was written for anyone interested in medical device connectivity, but especially for founders and executives of medical device companies who are considering cloud connectivity for their devices,” said Chris DuPont, co-author, and CEO and cofounder of Galen Data. “Cloud-enabled healthcare innovation is poised to help millions across a range of conditions. Understanding the realistic costs and risks associated with medical device cloud connectivity is critical (and often overlooked) in the early stages of development.”

The newly released whitepaper clarifies device connectivity needs, including hardware and software considerations, regulatory, security, and privacy issues, and more. Armed with this knowledge medical device innovators can confidently make decisions about connecting their medical devices to the cloud.

About Galen Data:

Galen Data, Inc. provides a turnkey cloud solution for medical device makers that is configurable, secure, and compliant. The company was founded to make device-to-cloud connectivity possible in a matter of weeks instead of months, and at a fraction of the cost. The Galen Cloud™ collects and securely stores data, and includes tools to visualize and analyze that data. Dashboards and alerts for the manufacturer, medical team, and patients are also provided within the platform. The Galen Cloud is compliant with FDA, HIPAA, and CE Mark standards, and is ISO 13485:2016 certified. Dozens of companies have partnered with Galen Data to solve their medical device connectivity needs.

Share article on social media or email:

Jvion Selected as Winner of 2020 Georgia Healthcare Innovation Challenge (GHIC)


News Image

We ultimately chose Jvion for their ability to rapidly integrate and enhance our current claims data with extensive insights around key social determinants of health.

Jvion, a leader in prescriptive clinical artificial intelligence (AI), announced today it was selected as a winner of the 2020 Georgia Healthcare Innovation Challenge (GHIC), in which healthcare technology vendors compete to solve the problems facing medical providers in Georgia and beyond. As a winner, Jvion will begin conducting a beta test of its clinical AI solution with Navicent Health, a nonprofit health system with 1,000 beds and more than 50 facilities across central and south Georgia.

Jvion won Challenge #1, which was presented by TC2, an ACO serving Medicare beneficiaries in Middle Georgia. TC2 was looking for a solution that would identify beneficiaries at “rising risk” for readmissions, ED visits and inpatient utilization, enabling earlier interventions to prevent these adverse outcomes. Jvion’s clinical AI solution, the Jvion CORE™, addresses the problem by analyzing over 4,500 clinical, socioeconomic, and behavioral risk factors per patient to predict who is at rising risk, why they are at risk, and what interventions can address these risk factors to transform patients’ trajectories. A video overview of the solution can be found here.

“We had four great finalists, each able to meaningfully advance TC2’s predictive modeling capabilities for rising risk beneficiaries,” said Dale Boylston, CEO of TC2. “We ultimately chose Jvion for their ability to rapidly integrate and enhance our current claims data with extensive insights around key social determinants of health. The result will substantially improve our ability to identify, engage, and assist patients before they require expensive inpatient care.”

Navicent Health, in partnership with Atlanta Tech Village, Georgia HIMSS, and TAG Digital Health, launched the 2020 GHIC on July 30th. For 13 weeks, the participants met with Navicent company CEOs and mentors, prepared product demos, and developed their company pitches. The challenge came to an end with a pitch competition on October 29th, where seven finalists presented for the chance to conduct beta tests with Navicent Health.

“We’re incredibly proud to collaborate with TC2 and Navicent Health to prevent avoidable patient harm and mitigate financial risk,” said Jay Deady, CEO of Jvion. “By winning this competition, we’ve shown that Jvion’s prescriptive AI is a potent solution for the issues facing providers in Georgia and around the country. Our hope is that our work with Navicent and TC2 can be a model for value-based care providers everywhere, especially now as they confront the challenge of improving patient outcomes despite widespread deferred care.”

Jvion has been actively involved in helping healthcare providers, payers and pharmacy benefit managers navigate the challenges of the pandemic, beginning with a suite of resources to help public health stakeholders prepare and intervene to protect their most vulnerable patients from Covid-19. Jvion has also helped healthcare organizations mitigate the financial impact of the pandemic, with solutions that help prevent uncompensated care and patient deterioration as a result of deferred care. More information on Jvion’s provider solutions can be found here.

For more information on the challenge, please visit http://www.gahealthcareinnovationchallenge.com.

About Jvion:

Jvion, a leader in clinical artificial intelligence, enables providers, payers and other healthcare entities to identify and prevent avoidable patient harm, utilization and costs. An industry first, the Jvion CORE™ goes beyond predictive analytics and machine learning to identify patients on a trajectory to becoming high-risk. Jvion then determines the interventions that will more effectively reduce risk and enable clinical and operational action. The CORE accelerates time to value by leveraging established patient-level intelligence to drive engagement across healthcare organizations, populations, and individuals. To date, the Jvion CORE has been deployed across hundreds of clients and resulted in millions saved. For more information, visit https://www.jvion.com.

Jvion PR Contact:

Lexi Herosian

lexi@scratchmm.com

Share article on social media or email:

Coils to Locs Expands Availability of Wigs for Women Experiencing Medical Hair Loss with First Cancer Center Partner in the Southwest


News Image

The Keisha wig, a new style offered from Coils to Locs

“I know all too well the struggles that Black women experiencing medical hair loss face,” said Dianne Austin, CEO and Co-Founder of Coils to Locs

Coils to Locs, a supplier of coily, curly synthetic wig styles, today announced the expansion of the company into Houston, Texas, bringing their wig line to Canopy at Memorial Hermann The Woodlands Medical Center. Canopy is a first-of-its-kind survivorship center and a place where cancer patients, survivors and their families can come for free support, resources, and programs. Building on this momentum, the company also introduced seven new wig styles available in medium auburn or golden copper ombre color options. The company, founded by sisters Dianne Austin and Pamela Shaddock after Dianne’s personal experience with cancer, was created to address a health care disparity that has traditionally been overlooked – until now.

“We are honored and excited to be able to offer Coils to Locs wigs to our guests here at Canopy. It is so important that we are representative of all of the women who come to us looking for a safe haven. Cancer is hard enough – you should be able to find a wig that is true to who you are and makes you feel beautiful and empowered. It is important to us that every patient feels seen and valued,” said Amanda Poole, Canopy Manager.

“I know all too well the struggles that Black women experiencing medical hair loss face,” said Dianne Austin, CEO and Co-Founder of Coils to Locs. “When I was losing my hair during my cancer battle, my first thoughts were how ironic it was that I went down this path of embracing my natural hair just to lose every strand of it. I was unable to find wigs in my natural coily, curly style that were both fit for someone with hair loss and available through my insurance. Coils to Locs was founded to empower women everywhere to maintain their unique personal style while experiencing medical hair loss. All women, regardless of hair type, should be able to walk into a cancer center boutique or medical salon and find something that looks like the hair that grows out of their heads. Our expansion into a new market means the demand for these wigs is universal and we’re so excited to bring these wigs to new guests at the Canopy at Memorial Hermann The Woodlands.”

Based on their own market research, Coils to Locs is the only medical wig company offering coily, curly styles for women to be sold within cancer center boutiques and available through insurance. One of the main differences between a medical wig and traditional wig is that a traditional wig cap uses combs to attach to the wearer’s head – something that is not feasible for medical wigs when most wearers do not have any hair. Because medical hair loss often causes a sensitive scalp, patients don’t want a comb scratching their head – medical wigs are made of a softer, more comfortable material without any combs. Coils to Locs has a deeply personal understanding of the needs of their target customer and, because of this, have been sought after by numerous Cancer Centers and Boutiques.

“We were so happy to find a line that was so realistic looking,” said Patricia A. Wrixon, owner and founder of the Salon at 10 Newbury, Boston. “These high quality wigs are easy to style, durable and are of good quality. In addition to carrying these coily-curly wigs at the salon, donors can purchase the wigs and gift them to Wigs for Wellbeing, our non-profit fund for cancer patients who do not have the means or insurance to purchase these natural textured wig styles.”

In addition to expanding to a new market, Coils to Locs also announced several new wig styles including a “faux locs” style and wigs in a variety of lengths from fashion-forward short tailored styles, to trendy long coily, curls. The company is also piloting a hat with hair sewn in that can be worn as an alternative to a full wig.

For more information about each product Coils to Locs offers, and to find your nearest cancer center boutique, visit coilstolocs.com.

About Coils to Locs

Coils to Locs is on a mission to provide access to a variety of ethnically inspired wigs that can be purchased through healthcare reimbursement at cancer center hospitals. Coils to Locs is a supplier of coily, curly synthetic wig styles for Black women (or any woman with textured hair) experiencing hair loss due to a medical diagnosis. The company is addressing a healthcare disparity for cancer patients of color who lack access to high-quality coily, curly textured wigs covered by health insurance through a medical prescription. The business is a family affair; founded by Dianne Austin and her sister and co-founder, Pamela Shaddock, Coils to Locs is also supported by their cousin Cheryl McCloud, VP of Communications & Business Development.

Share article on social media or email:

Airside and Tascent Partner to Bring Integrated COVID Solution to Travel Industry


Most digital transactions with sensitive personal information needed for identity proofing end up in a database, making them available for marketing purposes,” said Jessica Patel, Chief Revenue Officer at Airside. “We don’t think data privacy should be sacrificed for the sake of convenience.”

Digital identity innovator Airside has teamed up with intuitive biometrics leader Tascent Inc. to deliver an integrated, biometric recovery solution for the travel industry, heavily-impacted by COVID-19. Developed to help airlines and airports deliver their services in a safe and timely fashion, the Airside-Tascent solution offers secure, seamless, and touchless biometric technology for travelers to use across many points along their journey. The partnership is a result of the synergy between the two U.S.-based technology pioneers that combines years of technical expertise and top-performing products, based on providing superlative user experiences and built in accordance with data privacy standards and regulations.

Airlines and airports have quickly adapted to COVID-19, innovating at record speed to meet public health guidance. In parallel, travelers are proving their ability to manage a multitude of important safety measures at every step of the journey, from trip planning to returning home. However, the emerging safety and security processes have been met with new challenges, such as long queues, shared touchpoints, and unqualified and ineffective temperature check products.

“What’s more, is that most of these digital transactions involving sensitive personal information needed for identity proofing end up in some sort of database, making them available for marketing purposes and vulnerable to theft and fraud,” said Jessica Patel, Chief Revenue Officer at Airside. “We don’t think data privacy should be sacrificed for the sake of convenience.”

Airside and Tascent have integrated COVID-based solutions into their industry-leading technologies and, today, announce their interoperability and applied use in air travel.

“We’ve seen incredible changes in the aviation industry,” said Alastair Partington, CEO of Tascent, Inc. “We’re focused on helping to solve the big-picture issues across the system, rather than just implementing a stand-alone tool. By innovating and combining best-of-breed capabilities, we addressed specific challenges faced by aviation stakeholders today – improving safety for everyone on the ground and on board, keeping operations agile, and boosting traveler confidence and overall satisfaction.” Both companies consider efficiency, accuracy, and self-service as key requirements for today’s air travel experience.

The Airside-Tascent end-to-end solution provides travelers with personalized service, empowering them to control how their personal information and biometrics are used as part of their air travel experience.

The process starts with an easy mobile enrollment using the Airside Digital Identity App. This consent-driven digital identity management app connects travelers and businesses by enabling biometric identity verification and the sharing of personal information, such as driver’s licenses, passports, and lab test results. Travelers can conveniently add and verify their personal information in one single install, then decide when to securely share this information with their airline or other relying party.

On the day of travel, the person can breeze through the airport using Tascent’s InSight Face cooperative facial recognition system. Optimized for the aviation environment and integrated with airlines’ self-service check-in kiosks and bag drop units and airports’ security checkpoints, the InSight Face captures high-quality biometric images, enabling best-in-class facial matching via Tascent’s Enterprise Suite against the personal information already provided via the Airside App. The InSight Face device is available with additional capabilities, including External Body Temperature checking (InSight Face EBT), which meets current FDA Guidelines for Telethermographic Systems used for COVID-19 EBT measurements.

The combination of the Airside and Tascent technologies creates an important recovery solution that enables large-scale, seamless, and, most importantly, safe operations while sharing the sensitive information needed for air travel today.

Using the Airside-Tascent solution, the travelers maintain control of their personal information while moving swiftly along their journey in a streamlined, intuitive way. The Airside-Tascent integrated recovery solution provides new options for airlines, airports, and travelers, and is available for immediate application.

About Tascent

Tascent harnesses the power of biometrics to enable the frictionless flow of people and transactions in a connected world. We focus on creating intuitive hardware, software, and services, providing comprehensive capabilities for tailored identity solutions. Through partnerships, we deliver the strength of trusted identity to positively impact travel, financial services, ticketing and events, workplace access, government services, and humanitarian efforts.

While many biometric companies offer products that are complex and counterintuitive, Tascent makes it easy for our partners to integrate and deploy robust, intuitive approachable, and multimodal biometric identity systems. Today, our biometric solutions serve tens of millions of people each year in some of the most challenging environments. We strive to innovate and create products that address unmet needs for critical-yet-routine identity processes, making lives simpler and easier.

Based in Silicon Valley, CA, Tascent supports customers and partners globally through our partner network. https://tascent.com

About Airside

Airside builds secure and convenient digital identity technology in a manner that protects personal information and meets privacy regulations around the world. With Airside’s products and services, people are empowered to control their personal information with transparent consent protocols, and businesses can protect against fraud, reduce the burden of complying with privacy regulations and ensure a duty-of-care by appropriately managing sensitive information. Airside’s first product, Mobile Passport, has been downloaded by more than 9 million people and is counted on by more than 30 U.S. airports and cruise ports to reduce shared touchpoints, long lines, and crowding. Airside is headquartered in Arlington, Virginia. Learn more at: https://www.airsidemobile.com or follow us on Twitter, Facebook, Instagram, and LinkedIn.

Air Animal Pet Movers Outlines Critical Pet Vaccinations Required for Relocations


Grey-eyed husky dog.

Air Animal helped Shiloh move from Florida to Washington state in October

Air Animal pet move managers advise clients about requirements and veterinary protocols for every destination around the globe.

Planning a move across the U.S. or moving abroad with a pet? Air Animal Pet Movers® has the experience needed to ensure that the pet move will be safe, comfortable and comply with all government and airline regulations. Air Animal pet move managers specialize in geographic regions of the world. They advise clients about requirements and veterinary protocols for every destination. Air Animal posts the most common destination protocols at airanimal.com.

Air Animal can take care of:

  • Country-specific microchips– complimentary for Air Animal clients
  • Origin health certificates
  • Country-specific health certificates
  • Vaccination and parasite treatment explanations
  • Import permits
  • Air cargo bookings
  • Mandatory quarantine arrangements where applicable

“Vaccinations and other treatments required vary widely,” advises Walter Woolf, Air Animal veterinarian founder and CEO. The most common requirements are:

  • Proof of two rabies vaccinations the most recent administered within the past year.
  • Proof of DA2PPL/DAPPL vaccinations (distemper, hepatitis, parvovirus, parainfluenza and leptospirosis) for dogs.
  • Proof of FVRCP vaccinations (feline rhinotracheitis, calcivirus, and panleukopenia) for cats.
  • Internal and external parasite treatments within 10 days of relocation.

“We strongly urge clients who move overseas immediately register with a local veterinarian to keep their pet’s rabies and other vaccinations up to date. Veterinarians typically send reminder notices when vaccinations are due. If another move is in their future, they and their pets will be ready,” said Cory Robinette, Air Animal COO.

“We work with families relocating for a military Permanent Change of Station, contract employees with the Department of Defense, corporate transferees and relocation management firms,” she added.

Pet Moving Made Easy®. It’s their focus, their passion, their promise and their clients’ peace of mind.

About Air Animal

Air Animal has helped more than 55,000 families move their 110,000 furry, feathered and scaly pets around the globe since 1977. They welcome pet move authorizations and referrals from major corporations, relocation management agencies, household goods movers, veterinarians, families, U.S. military and government transferees. Get the best in animal care and transportation. Air Animal is an appointed and endorsed IATA air cargo sales agency working with all airlines that move animals. They are an Indirect Air Carrier cleared for tendering live animals to airlines by the U.S. Transportation Security Administration. See airanimal.com to learn more about Pet Moving Made Easy®.

Share article on social media or email:

Cloudticity Oxygen™ Upgraded to Harness Secure Healthcare Data and Applications in Multi-Cloud Environments


Healthcare companies often ask us how to navigate the spaghetti of frameworks in their cloud environments… Oxygen’s next-gen customer console delivers these views and insights by providing a central location to easily monitor multi-cloud configurations, compliance, and security.

Cloudticity™, a next-gen managed services, compliance, and security partner for healthcare companies, has expanded the capabilities of Cloudticity Oxygen™—the company’s HITRUST-certified managed cloud solution for healthcare. The new Oxygen application client console has been strategically redesigned to easily monitor, manage, and secure multi-cloud deployments. It’s the first console to provide a single-source view of framework-to-framework compliance mapping across both AWS and Microsoft Azure cloud environments, satisfying the complex data management and protection requirements of companies working with healthcare data.

COVID-19-inspired trends are driving transformation across the healthcare industry. In the face of surging needs, healthcare organizations are modernizing antiquated data systems and migrating to public clouds such as AWS and Azure. That said, in-house IT teams with limited resources and cloud expertise struggle to rapidly scale and manage cloud environments while also maintaining compliance with HIPAA and similar health data protection standards. Cloudticity Oxygen helps bridge this gap, making the cloud more accessible and continuously ensuring compliance, ultimately enabling greater innovation across the healthcare industry—all while resting on the secure foundation of Cloudticity’s HITRUST-certified platform.

Cloudticity Oxygen enables IT to unleash healthcare innovation via groundbreaking automation and deep cloud expertise. By offloading infrastructure operations, security, and compliance management to Oxygen, healthcare IT leaders can free up internal resources to focus on innovation. Unlike traditional managed cloud solutions that can provide a secure environment but offer limited flexibility or visibility, Oxygen frees IT to deploy, retire, and configure multiple cloud services and check controls against requirements from multiple regulatory bodies. Oxygen functions as a monitoring and optimization umbrella that sits over an environment and its resources. Customers have complete control over their production environments, while maintaining full security and compliance oversight.

To address the need for greater clarity and agility in cloud environments, Cloudticity redesigned both Oxygen’s user interface (UI) and user experience (UX). Customers are now able to visualize a single screen how their system is working at a universal level. Utilizing framework-to-framework compliance mapping across multiple cloud providers is a big step forward for healthcare IT, and establishes a model for potential application in other highly regulated industries.

“Healthcare companies often ask us how to navigate the spaghetti of frameworks in their cloud environments. They want to know if their cloud strategy is sound, their system is robust and safe, and how they can prove it,” said Rob Williams, director of technology and product management at Cloudticity. “Oxygen’s next-gen customer console delivers these views and insights by providing a central location to easily monitor multi-cloud configurations, compliance, and security. Customers get a single-pane-of-glass view across their entire environment, both clouds and all the services.”

To learn more about Cloudticity Oxygen’s revolutionary approach to managed services, read AIOps and Automation: Key Ingredients to Intelligent Managed Service Delivery or schedule a consultation.

About Cloudticity

Founded in 2011, Cloudticity helps healthcare organizations radically reshape healthcare by unlocking the full potential of the cloud. Through groundbreaking automation and deep cloud expertise, Cloudticity solutions empower healthcare organizations to create and scale the next generation of healthcare solutions. Distinguished for having built some of the earliest and largest health systems on the cloud, including the first patient portal, the first health information exchange (HIE), the first FISMA high deployment, and the first Meaningful Use 2 (MU2) compliance attestation for a large hospital system, Cloudticity enables healthcare to thrive in the digital era. Innovate faster, improve care, maintain compliance, and drive long-term growth with Cloudticity managed solutions. For more information, visit http://www.cloudticity.com.

Media Contact:

Sterling Communications

Michelle Denny

+1 (408) 335-7331

cloudticity@sterlingpr.com

Share article on social media or email:

The Laboratory for Research in Complex Systems Adds Standouts to Growing Team


News Image

“Bringing different scientific viewpoints to the table is the key to solving many of the wide-ranging problems faced by our clients and society as a whole.”

On the heels of a recent Moore Foundation grant and prestigious DARPA award, LRC Systems, developer of powerful quantitative research-based solutions that drive scientific, commercial and social breakthroughs, announced today the appointments of Dr. José Jaramillo-Villegas, Daniel Ling and Dr. Carlos Andres Melo Luna to LRC Systems’ growing team of notable researchers, academics and scientists – along with Dana White, MBA, joining as Director of Finance.

“At this point in our business, it is essential to expand our team with brilliant individuals who are also innovators in their respective fields,” said Dr. Shailesh Date, founder and CEO of LRC Systems. “Drs. Villegas and Luna, along with Daniel Ling have dynamic backgrounds and a range of accomplishments in areas that will help support LRC’s high-impact research in complex systems, transcending disciplines and sectors. Bringing different scientific viewpoints to the table is the key to solving many of the wide-ranging problems faced by our clients and society as a whole.”

Jaramillo-Villegas, a 2012 Fullbright Scholar, joins the LRC after a stint in academia that followed graduate studies in high-performance computing, photonics and quantum computing at Purdue and Universidad Tecnológica de Pereira (Colombia). “I am thrilled to be a part of advancing discoveries in areas related to the sciences, society, human health and climate change,” said Dr. Jaramillo-Villegas.

Ling, who was a US Presidential Scholar and a National Merit Scholar at Princeton, comes to the LRC as an Applied Mathematics Fellow, concentrating on research in complex systems across biological and economic contexts. Ling is formerly of Point Judith Capital and Morgan Stanley. “I’m eager to contribute to valuable ‘blue sky’ research as the LRC’s innovations, grants, and funding momentum continue.” Luna joins as a Research Scientist and will lend his expertise in light-matter interaction to help the LRC explore the origins and evolution of biological complexity.

“With the addition of Drs. Jaramillo-Villegas and Luna, the LRC will now have an international presence in Latin America, enabling us to extend our global footprint as we scale and grow,” said Dr. Date. “Additionally, Dana adds the oversight and financial prowess to help us monetize and scale our innovative approach,” he added. As the new Director of Finance for the LRC, Ms. White brings an impressive background in biotech, government and the banking industry. She previously held positions at Blue Canyon Technologies, NEON, Inc. and KPMG.

For more information about the LRC team and its game-changing approach, visit https://www.lrc.systems/.

About LRC Systems

Laboratory for Research in Complex Systems (LRC) develops powerful research-based solutions that drive scientific, commercial and social breakthroughs. Led by a team of trailblazers from industry and academia, LRC uniquely combines advances in natural and quantitative sciences with cutting-edge technology to help solve fundamental health, economic and social problems for public and private organizations. LRC serves as an ideas hub for high-level transdisciplinary research that is bigger, faster and more impactful, to propel innovations that can change the world.

Share article on social media or email: